Autopsy report · NCT04563299

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

“Subject Enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 years 2 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Retina Vitreous Associates of Florida

Sponsor type

University, hospital or other

Conditions

Neovascular Age-related Macular Degeneration; Diabetic Macular Edema; Retinal Vein Occlusion

Interventions

Dextenza 0.4Mg Ophthalmic Insert; Prednisolone Acetate

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence
  “Few subject enrolled” (78% match in meaning)
• AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY
  “Lack of subject enrollment” (78% match in meaning)
• Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
  “Low enrollment of qualified subjects” (73% match in meaning)
• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
  “Low subject recruitment and enrollment.” (73% match in meaning)
• The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
  “Study subject enrollment difficulties” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.